Adage Capital Partners Gp, L.L.C. Bio Techne Corp Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Bio Techne Corp stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 323,500 shares of TECH stock, worth $24.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

323,500

Holding current value

$24.6 Million

% of portfolio

0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$70.96 - $82.35 $23 Million - $26.6 Million	323,500 New	323,500 $25.9 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $10.4 Million - $15.4 Million	197,100 Added 125.94%	353,600 $27.3 Million
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $27,008 - $35,768	-400 Reduced 0.25%	156,500 $10.7 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $5.49 Million - $6.4 Million	74,400 Added 90.18%	156,900 $12.8 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $1.23 Million - $1.49 Million	-17,200 Reduced 17.25%	82,500 $6.12 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $4.82 Million - $21 Million	59,700 Added 149.25%	99,700 $8.26 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $254,286 - $352,665	-900 Reduced 2.2%	40,000 $11.4 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $32,267 - $44,965	-100 Reduced 0.24%	40,900 $14.2 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $318,465 - $439,011	-900 Reduced 2.15%	41,000 $17.8 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $18.6 Million - $22.6 Million	41,900 New	41,900 $20.3 Million
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $7.27 Million - $8.09 Million	-60,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $6.82 Million - $7.43 Million	60,000	60,000 $7.25 Million

Others Institutions Holding TECH

# of Institutions

603

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.99B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Bio Techne Corp Transaction History